Silva Pharmaceuticals Limited reported earnings results for the second quarter and six months ended December 31, 2022. For the second quarter, the company reported sales was BDT 184.65 million compared to BDT 195.96 million a year ago. Net income was BDT 19.25 million compared to BDT 29.78 million a year ago. Basic earnings per share from continuing operations was BDT 0.14 compared to BDT 0.22 a year ago.
For the six months, sales was BDT 382.3 million compared to BDT 411.82 million a year ago. Net income was BDT 45.01 million compared to BDT 68.89 million a year ago. Basic earnings per share from continuing operations was BDT 0.33 compared to BDT 0.5 a year ago.